This year, more than 5 million Americans will be diagnosed with Heart Valve Disease. All too often, for Black patients with certain forms of the disease this can be a death sentence, with patients from minority communities facing significantly higher mortality rates than their white counterparts. The most common form of this disease is aortic stenosis (AS), where the aortic valve narrows and weakens the heart. While common, AS can be deadly, and one in six patients will have a more aggressive form called symptomatic severe aortic stenosis (SSAS), that can be fatal within two years without treatment. Diseases like SASS and other chronic diseases lay bare stark inequities in our health care system, in which our Black patients are disproportionately impacted. When we see patients with SSAS, treatment options include two approaches to repair their failing valve, one that involves open-heart surgery and one that is minimally invasive. The latter, transcatheter aortic valve replacement (TAV